UBS Maintains a 'Buy' on Cardinal Health (CAH); Color on Safeway Contract

May 4, 2012 2:16 PM EDT
Get Alerts CAH Hot Sheet
Price: $235.17 +1.70%

Rating Summary:
    17 Buy, 10 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Buy' on Cardinal Health (NYSE: CAH) price target lowered from $51 to $50.

Analyst, Steven Valiquette, said, "CAH management officially confirmed what was already generally known that the Safeway (NYSE: SWY) drug distribution contract was won from McKesson (NYSE: MCK). Mgmt clarified the contract includes both brands and generics (some conjectured that SWY may revert back to buying generics direct, but CAH refuted this notion). This ~$3 bil annual contract should add $0.09-0.11 EPS for CAH (w/ est. 1.00-1.25% net margin). CAH also confirmed both its Walgreen (NYSE: WAG) & CVS (NYSE: CVS) contracts are set to renew in mid-‘13." (UBS raises FY13 EPS from $3.65 to $3.58)

For an analyst ratings summary and ratings history on Cardinal Health click here. For more ratings news on Cardinal Health click here.

Shares of Cardinal Health closed at $43.33 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

UBS